Evidence map›Paper›PMID 38133449›Full record

ArticleTropical medicine and infectious disease2023

In Vitro Activities of Dithiocarbamate Derivatives against

Marc Kaethner, Georg Rennar, Tom Gallinger, Tobias Kämpfer, Andrew Hemphill, Patrick Mäder, Ana Luque-Gómez, Martin Schlitzer, Britta Lundström-Stadelmann

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Marc KaethnerInstitute of Parasitology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0001-8582-8517
Georg RennarInstitute of Pharmaceutical Chemistry, Philipps-Universität Marburg, 35037 Marburg, Germany.
Tom GallingerInstitute of Pharmaceutical Chemistry, Philipps-Universität Marburg, 35037 Marburg, Germany.
Tobias KämpferInstitute of Parasitology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
Andrew HemphillInstitute of Parasitology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0002-0622-2128
Patrick MäderInstitute of Pharmaceutical Chemistry, Philipps-Universität Marburg, 35037 Marburg, Germany.
Ana Luque-GómezInstituto de Síntesis Química y Catálisis Homogénea (ISQCH), Facultad de Ciencias, Universidad de Zaragoza-CSIC, 50009 Zaragoza, Spain.ORCID 0000-0002-0132-6577
Martin SchlitzerInstitute of Pharmaceutical Chemistry, Philipps-Universität Marburg, 35037 Marburg, Germany.
Britta Lundström-StadelmannInstitute of Parasitology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0003-2672-5766
Philipps University of Marburg · DEUniversity of Bern · CHUniversidad de Zaragoza · ES

Funding

Swiss National Science Foundation 192072
6 · The paper itself

Abstract

The metacestode stage of the fox tapeworm

Indexed as

disulfiramdrug treatmentEchinococcusin vitro drug screeningplatyhelminth

Identifiers

PMID38133449
PMCPMC10747736
OpenAlexW4389613510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.